Found: 47
Select item for more details and to access through your institution.
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Phenotypic and ultrastructural characterization of a medullary thymocyte acute lymphoblastic leukemia with cellular procoagulant activity.
- Published in:
- 1985
- By:
- Publication type:
- journal article
The National Hemophilia Foundation provides a model of a national blood monitoring system.
- Published in:
- 1996
- By:
- Publication type:
- commentary
THE COMPOSITION AND MANUFACTURE OF EARLY MEDIEVAL COLOURED WINDOW GLASS FROM SION (VALAIS, SWITZERLAND)—A ROMAN GLASS-MAKING TRADITION OR INNOVATIVE CRAFTSMANSHIP?*.
- Published in:
- Archaeometry, 2005, v. 47, n. 2, p. 361, doi. 10.1111/j.1475-4754.2005.00207.x
- By:
- Publication type:
- Article
Multiple congenital coagulopathies co-expressed with Von Willebrand’s disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
- Published in:
- Haemophilia, 2007, v. 13, n. 6, p. 685, doi. 10.1111/j.1365-2516.2007.01541.x
- By:
- Publication type:
- Article
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study.
- Published in:
- Haemophilia, 2005, v. 11, n. 2, p. 84, doi. 10.1111/j.1365-2516.2005.01068.x
- By:
- Publication type:
- Article
Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
- Published in:
- Haemophilia, 2005, v. 11, n. 2, p. 100, doi. 10.1111/j.1365-2516.2005.01075.x
- By:
- Publication type:
- Article
Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C.
- Published in:
- Haemophilia, 2004, v. 10, n. 5, p. 413, doi. 10.1111/j.1365-2516.2004.00919.x
- By:
- Publication type:
- Article
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2003, v. 9, n. 1, p. 38, doi. 10.1046/j.1365-2516.2003.00708.x
- By:
- Publication type:
- Article
Viral pharmacovigilance study of haemophiliacs receiving porcine factor VIII.
- Published in:
- Haemophilia, 2002, v. 8, n. 6, p. 798, doi. 10.1046/j.1365-2516.2002.00698.x
- By:
- Publication type:
- Article
Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America.
- Published in:
- Haemophilia, 2001, v. 7, n. 3, p. 235, doi. 10.1046/j.1365-2516.2001.00498.x
- By:
- Publication type:
- Article
Safety and potential usefulness of liver biopsy in HIV-seropositive haemophiliacs employing a transjugular venous approach.
- Published in:
- Haemophilia, 1997, v. 3, n. 3, p. 201, doi. 10.1046/j.1365-2516.1997.00111.x
- By:
- Publication type:
- Article
Methodologies for data collection in congenital haemophilia with inhibitors (CHwI): critical assessment of the literature and lessons learned from recombinant factor VIIa.
- Published in:
- Haemophilia, 2018, v. 24, n. 4, p. 536, doi. 10.1111/hae.13482
- By:
- Publication type:
- Article
Lenalidomide as a novel therapy for gastrointestinal angiodysplasia in von Willebrand disease.
- Published in:
- Haemophilia, 2018, v. 24, n. 2, p. 278, doi. 10.1111/hae.13419
- By:
- Publication type:
- Article
Acquired haemophilia in cancer: A systematic and critical literature review.
- Published in:
- Haemophilia, 2018, v. 24, n. 1, p. 43, doi. 10.1111/hae.13355
- By:
- Publication type:
- Article
Efficacy and safety of Nuwiq<sup>®</sup> (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures.
- Published in:
- Haemophilia, 2018, v. 24, n. 1, p. 70, doi. 10.1111/hae.13351
- By:
- Publication type:
- Article
Pinpointing clinical phenotypes - Is there evidence to support the use of a simple scoring system to define a milder bleeding phenotype in severe haemophilia A?
- Published in:
- Haemophilia, 2017, v. 23, n. 4, p. e380, doi. 10.1111/hae.13267
- By:
- Publication type:
- Article
Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.
- Published in:
- Haemophilia, 2017, v. 23, n. 4, p. 556, doi. 10.1111/hae.13214
- By:
- Publication type:
- Article
SIPPET trial: the answers.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Efficacy and safety of a VWF/ FVIII concentrate (wilate<sup>®</sup>) in inherited von Willebrand disease patients undergoing surgical procedures.
- Published in:
- Haemophilia, 2017, v. 23, n. 2, p. 264, doi. 10.1111/hae.13106
- By:
- Publication type:
- Article
Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A.
- Published in:
- Haemophilia, 2017, v. 23, n. 1, p. e43, doi. 10.1111/hae.13131
- By:
- Publication type:
- Article
Evidence-based guidelines support integrated disease management as the optimal model of haemophilia care.
- Published in:
- Haemophilia, 2016, v. 22, p. 3, doi. 10.1111/hae.12997
- By:
- Publication type:
- Article
Von Willebrand factor for menorrhagia: a survey and literature review.
- Published in:
- Haemophilia, 2016, v. 22, n. 3, p. 397, doi. 10.1111/hae.12898
- By:
- Publication type:
- Article
Pain in haemophilia: are we listening?
- Published in:
- 2016
- By:
- Publication type:
- Editorial
US experience with recombinant factor VIIa for surgery and other invasive procedures in acquired haemophilia: analysis from the Hemostasis and Thrombosis Research Society Registry.
- Published in:
- Haemophilia, 2016, v. 22, n. 1, p. e18, doi. 10.1111/hae.12852
- By:
- Publication type:
- Article
Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment.
- Published in:
- Haemophilia, 2015, v. 21, n. 3, p. 310, doi. 10.1111/hae.12621
- By:
- Publication type:
- Article
Managing chronic pain in adults with haemophilia: current status and call to action.
- Published in:
- Haemophilia, 2015, v. 21, n. 1, p. 41, doi. 10.1111/hae.12526
- By:
- Publication type:
- Article
ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective.
- Published in:
- Haemophilia, 2014, v. 20, n. 6, p. 17, doi. 10.1111/hae.12466
- By:
- Publication type:
- Article
Cardiovascular comorbidities are increased in US patients with haemophilia A: a retrospective database analysis.
- Published in:
- Haemophilia, 2014, v. 20, n. 4, p. 472, doi. 10.1111/hae.12339
- By:
- Publication type:
- Article
Prophylaxis in real life scenarios.
- Published in:
- Haemophilia, 2014, v. 20, p. 106, doi. 10.1111/hae.12425
- By:
- Publication type:
- Article
Prophylaxis in real life scenarios.
- Published in:
- Haemophilia, 2014, v. 20, p. 106, doi. 10.1111/hae.12425
- By:
- Publication type:
- Article
Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational Study in Hemophilia (DOSE)
- Published in:
- Haemophilia, 2013, v. 19, n. 4, p. 524, doi. 10.1111/hae.12113
- By:
- Publication type:
- Article
The Rodin (Research Of Determinants of INhibitor Development among PUPs with haemophilia) study: the clinical conundrum from the perspective of haemophilia treaters.
- Published in:
- Haemophilia, 2013, v. 19, n. 3, p. 351, doi. 10.1111/hae.12149
- By:
- Publication type:
- Article
The challenge of pain evaluation in haemophilia: can pain evaluation and quantification be improved by using pain instruments from other clinical situations?
- Published in:
- Haemophilia, 2013, v. 19, n. 2, p. 181, doi. 10.1111/hae.12023
- By:
- Publication type:
- Article
MASAC Consensus Conference: impediments to conducting clinical research in persons with haemophilia, von Willebrand's disease and rare bleeding disorders.
- Published in:
- Haemophilia, 2013, v. 19, n. 2, p. 188, doi. 10.1111/hae.12035
- By:
- Publication type:
- Article
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A.
- Published in:
- Haemophilia, 2012, v. 18, n. 5, p. 798, doi. 10.1111/j.1365-2516.2012.02789.x
- By:
- Publication type:
- Article
Outcomes of mentored, grant-funded fellowship training in haemostasis /thrombosis: findings from a nested case-control survey study.
- Published in:
- Haemophilia, 2012, v. 18, n. 3, p. 326, doi. 10.1111/j.1365-2516.2011.02626.x
- By:
- Publication type:
- Article
Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008.
- Published in:
- Haemophilia, 2012, v. 18, n. 2, p. 268, doi. 10.1111/j.1365-2516.2011.02692.x
- By:
- Publication type:
- Article
Health care expenditures for Medicaid-covered males with haemophilia in the United States, 2008.
- Published in:
- Haemophilia, 2012, v. 18, n. 2, p. 276, doi. 10.1111/j.1365-2516.2011.02713.x
- By:
- Publication type:
- Article
Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres.
- Published in:
- Haemophilia, 2012, v. 18, n. 1, p. 63, doi. 10.1111/j.1365-2516.2011.02554.x
- By:
- Publication type:
- Article
Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg.
- Published in:
- Haemophilia, 2011, v. 17, n. 4, p. 650, doi. 10.1111/j.1365-2516.2010.02483.x
- By:
- Publication type:
- Article
von Willebrand factor: what is its role in the immune response in haemophilia?
- Published in:
- Haemophilia, 2011, v. 17, n. 1, p. e235, doi. 10.1111/j.1365-2516.2010.02277.x
- By:
- Publication type:
- Article
von Willebrand disease in the 21st century: current approaches and new challenges.
- Published in:
- 2009
- By:
- Publication type:
- Report
Haemophilia: January 2009.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome.
- Published in:
- Haemophilia, 2008, v. 14, p. 49, doi. 10.1111/j.1365-2516.2008.01745.x
- By:
- Publication type:
- Article
Diagnosis and treatment of von Willebrand disease: new perspectives and nuances.
- Published in:
- Haemophilia, 2007, v. 13, p. 3, doi. 10.1111/j.1365-2516.2007.01581.x
- By:
- Publication type:
- Article